Drug Profile
Recombinant alpha Crystallin B - Serenity Bioworks
Alternative Names: CRYAB; DC TAB; HspB5; Recombinant human alpha B-crystallin - Delta Crystallon; Recombinant human CRYAB - Delta Crystallon; SER-101 - Serenity BioworksLatest Information Update: 29 Apr 2022
Price :
$50
*
At a glance
- Originator Delta Crystallon
- Developer Delta Crystallon; Serenity Bioworks
- Class Alpha crystallins; Recombinant proteins; Urologics
- Mechanism of Action Alpha-crystallin B chain replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Lupus nephritis
- Discontinued Amyotrophic lateral sclerosis; Multiple sclerosis; Progressive supranuclear palsy